Multiple sclerosis drug blocks HIV infection and transmission in human immune cells

(PLOS) An immunomodulatory drug called fingolimod, which is approved for the treatment of multiple sclerosis, blocks human immunodeficiency virus (HIV) infection and transmission in human immune cells, according to a study published August 13 in the open-access journal PLOS Pathogens by Postdoctoral Fellow Rachel Resop and Assistant Professor Alberto Bosque of The George Washington University, and colleagues. These preliminary findings suggest that this compound may be a promising novel therapy for HIV treatment and prevention.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news